MBX
MBX
NASDAQ · Pharmaceuticals

Mbx Biosciences Inc

$27.82
-0.32 (-1.14%)
As of Mar 24, 10:02 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +69.4% upside
Low Target $32.34
Average Target $47.13
High Target $55.83
Current Price $27.82
Current
$27.82
Target
$47.13
$32.34 $47.13 avg $55.83
Scenario Analysis
Bear Case
$32.34
16.2%
Low target
Base Case
$47.13
+69.4%
Avg target
Bull Case
$55.83
+100.7%
High target
Risk/Reward
6.2x
Highly favorable
Price in Context
52-Week High
$44.89
-38.0% from high
52-Week Low
$4.81
+478.8% from low
Target vs 52W High
$47.13
+5.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%